83 related articles for article (PubMed ID: 28950782)
1. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications.
Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M
Ann Med; 2006; 38(8):592-604. PubMed ID: 28950782
[TBL] [Abstract][Full Text] [Related]
2. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
[TBL] [Abstract][Full Text] [Related]
3. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
[TBL] [Abstract][Full Text] [Related]
4. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
Hum Mol Genet; 2008 Apr; 17(7):971-7. PubMed ID: 18084039
[TBL] [Abstract][Full Text] [Related]
5. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
[TBL] [Abstract][Full Text] [Related]
6. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
Schmid-Kubista KE; Tosakulwong N; Wu Y; Ryu E; Hecker LA; Baratz KH; Brown WL; Edwards AO
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5070-9. PubMed ID: 19553609
[TBL] [Abstract][Full Text] [Related]
7. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
[TBL] [Abstract][Full Text] [Related]
8. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.
Hughes AE; Orr N; Esfandiary H; Diaz-Torres M; Goodship T; Chakravarthy U
Nat Genet; 2006 Oct; 38(10):1173-7. PubMed ID: 16998489
[TBL] [Abstract][Full Text] [Related]
9. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (
Cantsilieris S; Nelson BJ; Huddleston J; Baker C; Harshman L; Penewit K; Munson KM; Sorensen M; Welch AE; Dang V; Grassmann F; Richardson AJ; Guymer RH; Graves-Lindsay TA; Wilson RK; Weber BHF; Baird PN; Allikmets R; Eichler EE
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4433-E4442. PubMed ID: 29686068
[TBL] [Abstract][Full Text] [Related]
10. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.
Martínez-Barricarte R; Recalde S; Fernández-Robredo P; Millán I; Olavarrieta L; Viñuela A; Pérez-Pérez J; García-Layana A; Rodríguez de Córdoba S;
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1087-94. PubMed ID: 22247456
[TBL] [Abstract][Full Text] [Related]
11. Sequence and Expression of Complement Factor H Gene Cluster Variants and Their Roles in Age-Related Macular Degeneration Risk.
Hughes AE; Bridgett S; Meng W; Li M; Curcio CA; Stambolian D; Bradley DT
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2763-9. PubMed ID: 27196323
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.
Zhao J; Wu H; Khosravi M; Cui H; Qian X; Kelly JA; Kaufman KM; Langefeld CD; Williams AH; Comeau ME; Ziegler JT; Marion MC; Adler A; Glenn SB; Alarcón-Riquelme ME; ; ; Pons-Estel BA; Harley JB; Bae SC; Bang SY; Cho SK; Jacob CO; Vyse TJ; Niewold TB; Gaffney PM; Moser KL; Kimberly RP; Edberg JC; Brown EE; Alarcon GS; Petri MA; Ramsey-Goldman R; Vilá LM; Reveille JD; James JA; Gilkeson GS; Kamen DL; Freedman BI; Anaya JM; Merrill JT; Criswell LA; Scofield RH; Stevens AM; Guthridge JM; Chang DM; Song YW; Park JA; Lee EY; Boackle SA; Grossman JM; Hahn BH; Goodship TH; Cantor RM; Yu CY; Shen N; Tsao BP
PLoS Genet; 2011 May; 7(5):e1002079. PubMed ID: 21637784
[TBL] [Abstract][Full Text] [Related]
13. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
Zhu L; Zhai YL; Wang FM; Hou P; Lv JC; Xu DM; Shi SF; Liu LJ; Yu F; Zhao MH; Novak J; Gharavi AG; Zhang H
J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734
[TBL] [Abstract][Full Text] [Related]
14. Complement factor H related proteins in immune diseases.
Skerka C; Zipfel PF
Vaccine; 2008 Dec; 26 Suppl 8():I9-14. PubMed ID: 19388158
[TBL] [Abstract][Full Text] [Related]
15. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
[TBL] [Abstract][Full Text] [Related]
16. Novel Mechanistic Interplay between Products of Oxidative Stress and Components of the Complement System in AMD Pathogenesis.
Du H; Xiao X; Stiles T; Douglas C; Ho D; Shaw PX
Open J Ophthalmol; 2016 Feb; 6(1):43-50. PubMed ID: 27668132
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.
Alic L; Papac-Milicevic N; Czamara D; Rudnick RB; Ozsvar-Kozma M; Hartmann A; Gurbisz M; Hoermann G; Haslinger-Hutter S; Zipfel PF; Skerka C; Binder EB; Binder CJ
Proc Natl Acad Sci U S A; 2020 May; 117(18):9942-9951. PubMed ID: 32321835
[TBL] [Abstract][Full Text] [Related]
18. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
19. Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted Sequencing.
Tschernoster N; Erger F; Walsh PR; McNicholas B; Fistrek M; Habbig S; Schumacher AL; Folz-Donahue K; Kukat C; Toliat MR; Becker C; Thiele H; Kavanagh D; Nürnberg P; Beck BB; Altmüller J
J Mol Diagn; 2022 Jun; 24(6):619-631. PubMed ID: 35398599
[TBL] [Abstract][Full Text] [Related]
20. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
